Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-23+267,650→ 267,650 totalExercise: $11.99Exp: 2033-02-22→ Common Stock (267,650 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.